---
schema_version: "secwatch.filing_event.v1"
accession: "0001178913-26-002797"
form_type: "8-K"
ticker: "LFWD"
cik: "0001607962"
company_name: "Lifeward Ltd."
filed_at: "2026-05-19T12:37:24+00:00"
generated_at: "2026-05-19T12:41:21.525096+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Lifeward appoints Keith D. Rose as Chief Medical Officer effective May 1, 2026

## Summary
- Keith D. Rose, M.D. appointed Chief Medical Officer effective May 1, 2026.
- Dr. Rose joined Lifeward in March 2023; most recently VP, Medical Affairs, Medical Director – Neurosciences.
- Prior experience includes Medical Director at Biocodex and Clinical Research Scientist at Novocure (NVCR).
- Holds M.D. from George Washington University; residency at Baylor College of Medicine.

## SEC filing metadata
- accession: 0001178913-26-002797
- form_type: 8-K
- ticker: LFWD
- cik: 0001607962
- company_name: Lifeward Ltd.
- filed_at: 2026-05-19T12:37:24+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1607962/000117891326002797/0001178913-26-002797-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1607962/000117891326002797/zk2635366.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001178913-26-002797
- JSON: https://secwatch.observer/filing/0001178913-26-002797.json
- Plain text: https://secwatch.observer/filing/0001178913-26-002797.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.